Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
News|Articles|August 17, 2023
Daily Dose: Role of Heavy Menstrual Bleeding in Iron Deficiency Anemia Overlooked
Author(s)Sydney Jennings
A daily dose of clinical news on Patient Care you may have missed.
Advertisement
Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
Last week, we reported on a review published in the American Journal of Obstetrics and Gynecology.
The study
An expert review of the relationship between heavy menstrual bleeding (HMB), iron deficiency (ID), and ID anemia (IDA) in reproductive-aged women.
The findings
According to authors, HMB, ID, and IDA often negatively impact the lives of reproductive-aged girls and women, as well as children they may bear.
Authors' commentary
"Although the World Health Organization and related funding organizations recognize that anemia is a highly prevalent worldwide contributor to disability disproportionally affecting reproductive-aged girls and women, in our opinion, [the organization is] missing a core root cause, if not the dominant cause: ID related to menstrual bleeding that exceeds a woman’s dietary intake."
Click here for more details.
Advertisement
Related to this article
TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.
Investigational CagriSema produced 23.1% to 26.7% weight loss across menopause stages at 68 weeks, with improvements in cardiometabolic risk factors.
TMS 2026: Nearly 67% of US women receiving elinzanetant achieved at least a 50% reduction in menopausal VMS frequency by week 12 in pooled phase 3 trial data.
TMS 2026: Only 21.7% of women initiated menopause hormone therapy, with significant racial disparities and low treatment persistence, a new study finds.
TMS 2026: OB/GYN visits had nearly 4-fold higher odds of menopause coding than family medicine visits, with disparities by race and insurance, a study found.
JoAnn Pinkerton, MD, discusses new research she presented at The Menopause Society 2026 Annual Meeting on elinzanetant for menopausal vasomotor symptoms.
TMS 2026: Women exercising at least 5 days a week reported lower perimenopause symptom scores across psychological, somatic, and urogenital domains.
Advertisement
Advertisement